FDA Fast Tracks Metformin Approval for Anti-Aging.

*

*

Two years ago, investigators convinced the FDA to green-light a human lifespan study of Metformin, a drug currently used as first-line treatment for blood sugar control in type 2 diabetes, and off-label for polycystic ovary syndrome, weight control, and cancer prevention. If successful, Metformin will be the first drug to be FDA-approved for the indication of aging.

TheBreakAway

Source: GreenMedInfo.com

Jennie Ann Freiman M.D.

May 15, 2017

The search for eternal life isn’t new, but how far we’ve come from the Holy Grail, the Fountain of Youth and the hidden valley of Shangri-La, is truly a sign of the times. Today, the crossroads meet between the natural tendency to find an easy way out, and the seductive promise of profits. The quest is on for how to put longevity in a pill. 

Classifying age as a disease means insurance companies will cover treatment.  The FDA just paved the way.

Two years ago, investigators convinced the FDA to green-light a human lifespan study of Metformin, a drug currently used as first-line treatment for blood sugar control in type 2 diabetes, and off-label for polycystic ovary syndrome, weight control, and cancer prevention. If successful, Metformin will be the first drug to be FDA-approved for the indication of aging, but…

View original post 1,215 more words